The new cell culture smallpox vaccine shouldnot be offered to the general population
- 1 January 2002
- journal article
- review article
- Published by Wiley in Reviews in Medical Virology
- Vol. 13 (1) , 17-20
- https://doi.org/10.1002/rmv.383
Abstract
Cell based smallpox vaccines are to be welcomed, but any decision to vaccinate whole populations must await firstly better intelligence about the gravity of the threat from bioterrorists, including their ability to release smallpox in such a way that wide dissemination could take place; secondly evidence that vaccines grown in cell culture are protective and safe; and thirdly that the vaccines would be generally acceptable and their introduction would not compromise the rest of national immunisation programmes. Smallpox vaccination should not be offered to the general population until these uncertainties have been resolved, by which time bioterrorism might possibly have been overcome or the development of antiviral treatment might have made renewed smallpox vaccination unnecessary. Meanwhile, preparations for rapid deployment of the historically well-tried containment measures at the epicentres of any smallpox release should proceed, their effectiveness should be tested, and their adequacy kept under review.Keywords
This publication has 7 references indexed in Scilit:
- Emergency response to a smallpox attack: The case for mass vaccinationProceedings of the National Academy of Sciences, 2002
- Studies in smallpox and vaccination†Reviews in Medical Virology, 2002
- Mass vaccination after a smallpox attack might be best, researchers suggestThe Lancet, 2002
- Smallpox Research Activities: U.S. Interagency Collaboration, 2001Emerging Infectious Diseases, 2002
- A Status Report on National Immunization against InfluenzaThe Journal of Infectious Diseases, 1976
- Smallpox in Europe, 1950-1971The Journal of Infectious Diseases, 1972
- FURTHER OBSERVATIONS ON THE CULTIVATION OF VACCINE VIRUS FOR JENNERIAN PROPHYLAXIS IN MANThe Journal of Experimental Medicine, 1933